A Single-centre, Randomized, Open-label, 2-arm, 4-week Treatment Study to Investigate the Beta Cell Function and Related Pharmacodynamics in Type 2 Diabetes Mellitus (T2DM) Patients
Latest Information Update: 21 Feb 2019
Price :
$35 *
At a glance
- Drugs Dorzagliatin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Proof of concept; Therapeutic Use
- Sponsors Hua Medicine
- 13 Aug 2015 Results published in a Hua Medicine media release.
- 13 May 2015 Status changed from not yet recruiting to completed, as reported by ClinicalTrials.gov.
- 17 Mar 2015 New trial record